Why are vaginal laser treatments not covered by most insurance?
Most insurance policies do not cover vaginal laser treatments because they are considered experimental, elective, or not supported by sufficient high-quality evidence for routine medical use.
Detailed Medical Explanation
Health insurers (including the NHS and most private insurers) classify vaginal laser for GSM, atrophy, or rejuvenation as an elective or cosmetic procedure, citing insufficient robust RCT evidence for widespread adoption. NICE guidance only recommends laser in select, carefully assessed cases, and not as standard care. Most policies explicitly exclude experimental or non-licensed treatments. For more, see NICE guidance and BUPA UK.
Clinical Context
Women should check with their insurer before booking laser procedures, and seek a written policy statement.
Evidence-Based Approaches
NICE and major UK insurers recommend full disclosure of funding status and evidence base for all private laser treatments. See NICE guidance.